RxDoctor Payments Data

Jane Elizabeth Watson Alford, MD

Psychiatry · Columbia, SCNPI 1447341623

Payments from drug & device makers

$1,148in general payments, 2019–2025

Across 84 payments — averaging $13.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$559
  • Alkermes, Inc.$130
  • Sunovion Pharmaceuticals Inc.$116
  • Otsuka America Pharmaceutical, Inc.$113
  • AbbVie$56
  • Lundbeck LLC$51
  • plus $125 from 6 others

What the payments were for

  • Food & beverage$1,148100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,148 in reported general payments places this provider in the 70th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$23,602
Medicare patients
46
Services billed
350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HetliozTasimelteon11$246,185
IngrezzaValbenazine Tosylate29$228,556
AustedoDeutetrabenazine12$86,447
Invega SustennaPaliperidone Palmitate18$62,955
VraylarCariprazine Hcl25$36,964
Lurasidone Hcl33$14,395
TrintellixVortioxetine Hydrobromide22$11,242
Clozapine63$3,730
Quetiapine Fumarate277$3,472
Duloxetine Hcl207$3,235
Haloperidol Decanoate56$2,712
Paliperidone ErPaliperidone23$2,099
Ramelteon27$1,955
Buspirone Hcl169$1,943
Gabapentin112$1,859

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Vanda Pharmaceuticals Inc.Hetlioz$27$246,18511 claims
Neurocrine Biosciences, Inc.Ingrezza$35$228,55629 claims
Teva Pharmaceuticals USA, Inc.Austedo$12$86,44712 claims
Johnson & JohnsonInvega Sustenna$559$62,95518 claims
AbbVieVraylar$56$36,96425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →